Post by Archer Insights

The transition from clinical to commercial breaks the close cycle first. Then revenue recognition. Then everything downstream. Companies that succeed at the commercialization handoff begin the back-office build in late Phase 2. The ones that wait until after approval, they spend a year cleaning up. In our whitepaper, Scaling Systems in Life Science, we match each requirement with the right time to address it. https://bit.ly/4eTBoV2 #Biotech #CFO #LifeSciences #ERP #ArcherInsights